QTREX Quantum Ltd(QTEX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 27 at 7:53 PM ET (Korea 10/28 08:53)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.35 | Insider Own | 14.4% | Shs Outstand | 67.1M | Perf Week | -7.53% |
| Market Cap | 0.09B | Forward P/E | - | EPS next Y | - | Insider Trans | 0.71% | Shs Float | 57.4M | Perf Month | 96.25% |
| Enterprise Value | 0.08B | PEG | - | EPS next Q | - | Inst Own | 11.49% | Short Float | 7.5% | Perf Quarter | 58.82% |
| Income | -0.01B | P/S | 58.42 | EPS this Y | - | Inst Trans | 1.33% | Short Ratio | 0.47 | Perf Half Y | 181.31% |
| Sales | 0.00B | P/B | 6.97 | EPS next 5Y | - | ROA | -106.42% | Short Interest | 4.31M | Perf YTD | 50% |
| Book/sh | 0.19 | P/C | 8.49 | EPS past 3/5Y | 31.48% 14.99% | ROE | -219.29% | 52W High | -64.94% ($3.85) | Perf Year | 26.17% |
| Cash/sh | 0.16 | P/FCF | - | Sales past 3/5Y | - | ROIC | -109.91% | 52W Low | 377.03% ($0.28) | Perf 3Y | 5.47% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 24.01% | Gross Margin | 34.17% | Volatility(W/M) | 8.38% 17.17% | Perf 5Y | -66.25% |
| Dividend TTM | - | EV/Sales | 53.34 | Sales Y/Y TTM | 437.72% | Oper. Margin | -858.49% | ATR (14) | 0.18 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.62 | EPS Q/Q | 95.19% | Profit Margin | -847.88% | RSI (14) | 52.02 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2 | Sales Q/Q | - | SMA20 | -5.12% ($1.42) | Beta | 4.06 | Target Price | $5 |
| Payout | - | Debt/Eq | 0.26 | Earnings | 2026/9/24 | SMA50 | 26.01% ($1.07) | Rel Volume | 0.61 | Prev Close | $1.29 |
| Employees | 40 | LT Debt/Eq | 0.12 | EPS/Sales Surpr. | - | SMA200 | 39.94% ($0.96) | Avg Volume(3M) | 9.09M | Price | $1.35 |
| IPO | 2021/7/14 | Option/Short | No/Yes | Trades | 8979 | Volume | 5,511,807 | Change | 4.65% |
💡 QTREX (QTEX) Quantex is a healthcare technology company that specializes in researching, developing, and manufacturing innovative medical devices equipped with AI-based analysis algorithms and highly sensitive intelligent sensor modules for diagnosing neurological disorders and monitoring patients.
Over the past 1 year, roughly in the middle
65% below its 1-year high.
Traded less than usual. That is 61% of its average volume.
QTEX has a sound balance sheet but weak earning power
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $5,842. Peers typically go for $128.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -66.3%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 11.5%.
Tap to view numbers
It ranks #30 of 45 in the industry
Based on market cap of $91M.
FAQ
What kind of company is QTEX?
QTEX belongs to the Technology sector and operates in the Computer Hardware industry.
What is the market cap of QTEX?
The market cap of QTEX is approximately $91M, ranking 4,522 within its sector.
What is the 52-week high and low for QTEX?
QTEX has recorded a 52-week high of $3.85 and a low of $0.28.
